1332527-89-5Relevant articles and documents
TGF-beta SIGNAL TRANSDUCTION INHIBITOR
-
Paragraph 0223; 0224, (2013/03/26)
The present invention provides a compound represented by the following formula (I) or a physiologically acceptable salt thereof, and use thereof for the prophylaxis or treatment of TGF-β-related diseases: wherein Y is a hydrogen atom and the like; R2 is and the like; R3 is —NR8—R9— and the like; R4, R5, R6 and R7 are the same or different and each is a hydrogen atom and the like; and X is and the like.